Rotavirus G and P types circulating in the eastern region of Kenya: Predominance of G9 and emergence of G12 genotypes

Pediatric Infectious Disease Journal

Volumn 33, Issue SUPPL. 1, 2014, Pages

  Kiulia, Nicholas M ^a   Nyaga, Martin M ^b   Seheri, Mapaseka L ^b   Wolfaardt, Marianne ^c   Van Zyl, Walda B ^c   Esona, Mathew D ^d   Irimu, Grace ^e   Inoti, Murithi ^f   Gatinu, Bernard W ^g   Njenga, Peter K ^h   Taylor, Maureen B ^c,i   Nyachieo, Atunga ^a  

^a INSTITUTE OF PRIMATE RESEARCH   (Kenya)

^b SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^c UNIVERSITY OF PRETORIA   (South Africa)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f Maua Methodist Hospital   (Kenya)

^g Meru General Hospital   (India)

^h JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Kenya)

ⁱ NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

gastroenteritis; genotypes; rotavirus; vaccines

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE DIARRHEA; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL TRIAL; ENZYME IMMUNOASSAY; FECES ANALYSIS; GENOTYPE; HUMAN; INFANT; KENYA; MAJOR CLINICAL STUDY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; ROTAVIRUS G; ROTAVIRUS INFECTION; ROTAVIRUS P; VACCINATION;

CHILD, PRESCHOOL; FECES; GASTROENTERITIS; HUMANS; INFANT; KENYA; PREVALENCE; PROSPECTIVE STUDIES; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 84891591125     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000059     Document Type: Article

References (38)

1. Tate JE, Burton AH, Boschi-Pinto C, et al.; WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirusassociated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:136-141.
2. Sanchez-Padilla E, Grais RF, Guerin PJ, et al. Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. Lancet Infect Dis. 2009;9:567-576.
3. Parashar U, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009;200 (suppl 1):S9-15.
4. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22. (Pubitemid 43048947)
5. Vesikari T, Matson DO, Dennehy P, et al.; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33. (Pubitemid 43048948)
6. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370:1757-1763. (Pubitemid 350137490)
7. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:606-614.
8. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289-298.
9. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:615-623.
10. Salinas B, Pérez Schael I, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J. 2005;24:807-816. (Pubitemid 41324890)
11. Steele AD, Neuzil KM, Cunliffe NA, et al. Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis. 2012;12:213.
12. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362:299-305.
13. Pawinski R, Debrus S, Delem A, et al. Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa. J Infect Dis. 2010;202 (suppl):S80-S86.
14. de Oliveira LH, Danovaro-Holliday MC, Matus CR, et al. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev Vaccines. 2008;7:345-353. (Pubitemid 351520022)
15. Mwenda JM, Ntoto KM, Abebe A, et al. Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance Network. J Infect Dis. 2010;202 (suppl):S5-S11.
16. World Health Organization. Rotavirus vaccines: an update. Wkly Epidemiol Rec. 2009;84:533-40.
17. Estes M, Kapikian A. Rotaviruses. In: Knipe DM, Howley PM, Griffin DE, et al., eds. Fields Virology. 5th ed. Vol.2 Philadelphia: Wolters Kluwer/Lippincott Williams and Wilkins; 2007:1917-1974.
18. Matthijnssens J, Miño S, Papp H, et al. Complete molecular genome analyses of equine rotavirus A strains from different continents reveal several novel genotypes and a largely conserved genotype constellation. J Gen Virol. 2012;93(pt 4):866-875.
19. Gentsch JR, Laird AR, Bielfelt B, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis. 2005;192 (suppl 1):S146-S159. (Pubitemid 41193116)
20. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15:29-56. (Pubitemid 40070041)
21. Kiulia NM, Peenze I, Dewar J, et al. Molecular characterisation of the rotavirus strains prevalent in Maua, Meru North, Kenya. East Afr Med J. 2006;83:360-365. (Pubitemid 44671691)
22. Kiulia NM, Kamenwa R, Irimu G, et al. The epidemiology of human rotavirus associated with diarrhoea in Kenyan children: a review. J Trop Pediatr. 2008;54:401-405.
23. Kiulia NM, Nyaundi JK, Peenze I, et al. Rotavirus infections among HIVinfected children in Nairobi, Kenya. J Trop Pediatr. 2009;55:318-323.
24. Nokes DJ, Peenze I, Netshifhefhe L, et al. Rotavirus genetic diversity, disease association, and temporal change in hospitalized rural Kenyan children. J Infect Dis. 2010;202 (suppl):S180-S186.
25. World Health Organization. Generic Protocols for (I) Hospital-based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis in Children and (II) a Community-based Survey on Utilization of Health Care Services for Gastroenteritis in children. Field Test Version. WHO/V&B/02.15. Geneva: World Health Organization; 2002.
26. Gouvea V, Glass RI, Woods P, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol. 1990;28:276-282. (Pubitemid 20050935)
27. Gentsch JR, Glass RI, Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol. 1992;30:1365-1373.
28. Iturriza-Gómara M, Isherwood B, Desselberger U, et al. Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J Virol. 2001;75:3696-3705. (Pubitemid 32246379)
29. Iturriza-Gómara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol. 2004;31:259-265. (Pubitemid 39371057)
30. Nyangao J, Page N, Esona M, et al. Characterization of human rotavirus strains from children with diarrhea in Nairobi and Kisumu, Kenya, between 2000 and 2002. J Infect Dis. 2010;202 (suppl):S187-S192.
31. Page NA, de Beer MC, Seheri LM, et al. The detection and molecular characterization of human G12 genotypes in South Africa. J Med Virol. 2009;81:106-113.
32. Matthijnssens J, Heylen E, Zeller M, et al. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol Biol Evol. 2010;27:2431-2436.
33. Rahman M, Matthijnssens J, Goegebuer T, et al. Predominance of rotavirus G9 genotype in children hospitalized for rotavirus gastroenteritis in Belgium during 1999-2003. J Clin Virol. 2005;33:1-6. (Pubitemid 40431570)
34. Rahman M, Sultana R, Ahmed G, et al. Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh. Emerg Infect Dis. 2007;13:18-24.
35. Kirkwood CD, Bonifacea K, Bogdanovic-Sakran N, et al. Rotavirus strain surveillance-an Australian perspective of strains causing disease in hospitalised children from 1997 to 2007. Vaccine. 2009;27 (suppl 5):F102-F107.
36. Xu J, Yang Y, Sun J, et al. Molecular epidemiology of rotavirus infections among children hospitalized for acute gastroenteritis in Shanghai, China, 2001 through 2005. J Clin Virol. 2009;44:58-61.
37. Parra GI. Seasonal shifts of group A rotavirus strains as a possible mechanism of persistence in the human population. J Med Virol. 2009;81:568-571.
38. Page NA, Steele AD. Antigenic and genetic characterization of serotype G2 human rotavirus strains from the African continent. J Clin Microbiol. 2004;42:595-600. (Pubitemid 38222634)